Making the Case for Early Statins in Familial Hypercholesterolemia

Share this post

Results of a new 20-year follow-up study are a "call to action" to do more for patients with FH, who often go undiagnosed and untreated, an expert says.
Medscape Medical News

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.


Share this post

Be the first to comment

Leave a Reply